
"Sector" = median of Healthcare across 84 companies
Becton, Dickinson and Company (BDX) is a global medical technology company that manufactures and sells medical supplies, devices, laboratory equipment, and diagnostic products. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD operates through three segments: BD Medical, BD Life Sciences, and BD Interventional. The company serves healthcare institutions, clinical laboratories, and pharmaceutical companies worldwide.
BD generates revenue primarily from the sale of medical devices and diagnostic systems. The BD Medical segment offers syringes, needles, catheters, and infusion systems. BD Life Sciences provides diagnostic systems for infectious diseases and cancer, as well as labware. BD Interventional focuses on peripheral intervention, surgery, and urology products. In the latest fiscal year, total revenue was approximately $20.4 billion, with a gross margin of 45.44% and operating margin of 13.67%.
BD operates in the highly competitive medical instruments and supplies industry, facing rivals like Johnson & Johnson, Abbott Laboratories, and Boston Scientific. The company holds a strong position in safety-engineered medical devices and diagnostic systems. Despite a recent earnings decline due to restructuring and litigation charges, BD maintains a leading market share in areas such as medication management and infection prevention. Its EV/EBITDA of 9.25 and FCF yield of 7.55% indicate reasonable valuation and solid cash generation.
BD's primary customers are hospitals, clinics, diagnostic laboratories, and pharmaceutical companies. The company has a global footprint, with approximately 55% of revenue from the United States and the remainder from international markets. BD's products are used in over 190 countries, with significant presence in Europe, Asia Pacific, and emerging markets. The company's dividend yield of 2.20% appeals to income-focused investors, while its focus on innovation and safety addresses the needs of healthcare providers worldwide.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 10, 2026 | $1.05 | Mar 31, 2026 | Quarterly |
| Dec 8, 2025 | $0.83 | Dec 31, 2025 | Quarterly |
| Sep 8, 2025 | $0.82 | Sep 30, 2025 | Quarterly |
| Jun 9, 2025 | $0.82 | Jun 30, 2025 | Quarterly |
| Mar 10, 2025 | $0.82 | Mar 31, 2025 | Quarterly |
| Dec 9, 2024 | $0.82 | Dec 31, 2024 | Quarterly |
| Sep 9, 2024 | $0.75 | Sep 30, 2024 | Quarterly |
| Jun 10, 2024 | $0.75 | Jun 28, 2024 | Quarterly |
| Mar 7, 2024 | $0.75 | Mar 29, 2024 | Quarterly |
| Dec 7, 2023 | $0.75 | Dec 29, 2023 | Quarterly |
| Sep 7, 2023 | $0.72 | Sep 29, 2023 | Quarterly |
| Jun 8, 2023 | $0.72 | Jun 30, 2023 | Quarterly |
| Mar 9, 2023 | $0.72 | Mar 31, 2023 | Quarterly |
| Dec 8, 2022 | $0.72 | Dec 30, 2022 | Quarterly |
| Sep 8, 2022 | $0.68 | Sep 30, 2022 | Quarterly |
| Jun 8, 2022 | $0.68 | Jun 30, 2022 | Quarterly |
| Mar 9, 2022 | $0.67 | Mar 31, 2022 | Quarterly |
| Dec 9, 2021 | $0.67 | Dec 31, 2021 | Quarterly |
| Sep 8, 2021 | $0.64 | Sep 30, 2021 | Quarterly |
| Jun 8, 2021 | $0.64 | Jun 30, 2021 | Quarterly |
| Mar 9, 2021 | $0.64 | Mar 31, 2021 | Quarterly |
| Dec 9, 2020 | $0.64 | Dec 31, 2020 | Quarterly |
| Sep 8, 2020 | $0.61 | Sep 30, 2020 | Quarterly |
| Jun 8, 2020 | $0.61 | Jun 30, 2020 | Quarterly |
Wrqti brings Becton, Dickinson and Company data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Becton, Dickinson and Company:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.